XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.3
NON CONTROLLING INTEREST (Tables)
9 Months Ended
Sep. 30, 2024
NON CONTROLLING INTEREST  
Schedule of net loss attributable to non-controlling interest

 

 

BioCorRx

Pharmaceuticals,

Inc.

 

 

Joseph

DeSanto

MD

 

Net loss

 

$(106,233 )

 

$244

 

Average Non-controlling interest percentage of profit/losses

 

 

24.2%

 

 

35.0%

Net loss attributable to the non-controlling interest

 

$(25,708 )

 

$85

 

 

 

BioCorRx

Pharmaceuticals,

Inc.

 

 

Joseph

DeSanto

MD

 

Net loss

 

$(2,397 )

 

$(1,395 )

Average Non-controlling interest percentage of profit/losses

 

 

24.2%

 

 

35.0%

Net loss attributable to the non-controlling interest

 

$(580 )

 

$(488 )

 

 

BioCorRx

Pharmaceuticals,

Inc.

 

 

Joseph

DeSanto

MD

 

Net loss

 

$(175,033 )

 

$(1,720 )

Average Non-controlling interest percentage of profit/losses

 

 

24.2%

 

 

35.0%

Net loss attributable to the non-controlling interest

 

$(42,358 )

 

$(602 )

 

 

BioCorRx

Pharmaceuticals,

Inc.

 

 

Joseph

DeSanto

MD

 

Net loss

 

$(5,692 )

 

$(4,945 )

Average Non-controlling interest percentage of profit/losses

 

 

24.2%

 

 

35.0%

Net loss attributable to the non-controlling interest

 

$(1,378 )

 

$(1,730 )
Schedule of changes in non controlling interest

Balance, December 31, 2023

 

$(128,834 )

Net loss attributable to the non-controlling interest

 

 

(42,960 )

Balance, September 30, 2024

 

 

(171,794 )

Balance, December 31, 2022

 

$(125,257 )

Net loss attributable to the non-controlling interest

 

 

(3,108 )

Balance, September 30, 2023

 

 

(128,365 )